Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Inversa Implants

K-Number: K181850 · 2018-11-14

Decision Date2018-11-14
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Inversa Implants is a medical device manufactured by Southern Implants (Pty), Ltd.. It received FDA 510(k) clearance on 2018-11-14 under approval number K181850. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Inversa Implants?

Inversa Implants is a medical device that received FDA 510(k) clearance on 2018-11-14. It is manufactured by Southern Implants (Pty), Ltd.. The 510(k) number is K181850.

When was Inversa Implants approved by the FDA?

Inversa Implants received FDA 510(k) clearance on 2018-11-14, under approval number K181850.

What company makes Inversa Implants?

Inversa Implants is manufactured by Southern Implants (Pty), Ltd..

What is the FDA product code for Inversa Implants?

The FDA product code for Inversa Implants is DZE.

Other Devices by Southern Implants (Pty), Ltd.

View all 19 devices →

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.